Nexthera Capital’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-200,000
Closed -$680K 59
2018
Q3
$680K Buy
+200,000
New +$721K 0.13% 52

Nexthera Capital's KERX Position: Q4 2018 in Review

Nexthera Capital sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 200,000 shares — an estimated $680K sold.

Nexthera Capital first reported a position in KERX in Q3 2018 and held it in 1 quarter. The position peaked at $680K in Q3 2018. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • Nexthera Capital reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Nexthera Capital sold 200,000 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $680K.
  • Nexthera Capital first reported a position in Keryx Biopharmaceuticals Inc in Q3 2018 and held it in 1 quarter.
  • Nexthera Capital's Keryx Biopharmaceuticals Inc position peaked at $680K in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Nexthera Capital's 13F filing for Q4 2018, filed 14 Feb 2019.